Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05509283 · ClinicalTrials.gov registry record · NA
Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40,671
- Enrollment target
NCT05509283 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 40,671 participants.
The verdict
NCT05509283, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40,671 participants
- Enrollment target
Study Summary
This study will test the relative efficacy of high-risk messages in increasing flu shot rates in patients at moderately high risk for flu and complications (those in the top 11-20% of risk). It will also examine whether informing patients that their high-risk status was determined by analyzing their medical records or by an artificial intelligence (AI) / machine-learning (ML) algorithm analyzing their medical records will affect the likelihood of receiving a flu vaccine.
Interventions
- BEHAVIORAL Risk Reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,671 participants |
| Start Date | 2022-09-13 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05509283
The ClinicalTrials.gov registry entry for NCT05509283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40,671 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Risk Reduction is the first listed.
NCT05509283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05509283 about?
NCT05509283 is a clinical study titled "Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications". This study will test the relative efficacy of high-risk messages in increasing flu shot rates in patients at moderately high risk for flu and complications (those in the top 11-20% of risk). It will also examine whether informing patients that their high-risk status was determined by analyzing their...
What is the current status of trial NCT05509283?
This trial is currently completed. It is a NA study. The enrollment target is 40,671 participants. The study started on 2022-09-13. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT05509283?
The interventions under investigation include: Risk Reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT05509283?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.